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ABSTRACT 
Background and Objectives: Adult studies have reported that patients with diabetes mellitus (DM) show ultra-
structural and functional myocardial deterioration. The aim of this study was to assess whether cardiac functional 
deterioration can be detected in pediatric patients with type I DM and whether or not a relatively short duration 
of DM and hyperglycemia influences cardiac function. Subjects and Methods: Forty-seven children and adoles-
cents with DM and 38 healthy subjects (control group) were enrolled. Glycosylated hemoglobin (HbA1c), DM-
induced complications, and left ventricular (LV) function as assessed using conventional and unconventional echo-
cardiography {tissue Doppler imaging (TDI) and vector velocity imaging (VVI)} were evaluated. Results: The con-
ventional echocardiographic parameters, with the exception of early peak mitral inflow velocity, the findings of 
pulsed wave TDI at the annular level, and regional ventricular function by VVI, were not significantly different 
between the two groups. Using the conventional and unconventional indices of systolic and diastolic function, no 
significant relationship was found between the duration of DM and the echocardiographic parameters. The de-
celeration time (DT) and E’/A’ had an inverse correlation with HbA1c (p=0.042 and p=0.016, respectively). 
Conclusion: Patients with DM in childhood and early adolescence rarely have insight on the significance of DM, 
and their diet is difficult to control. An alteration of myocardial function induced by DM may begin earlier than 
generally thought, and these changes are accelerated when glycemic control is poor. We recommend the early 
institution of close observation of patients with diabetes for alterations in cardiac function, in addition to other 
diabetic complications. (Korean Circ J 2010;40:125-130) 
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Introduction 
 
Studies in adults have reported that patients with dia-
betes mellitus (DM) show ultrastructural and function-
al deterioration of the myocardium.
1)2) These patients 
are susceptible to heart failure and have a higher pre-
valence of coronary heart disease, hypertension, and car-
diomyopathy.
3-6)  
Deterioration of left ventricular (LV) function in pa-
tients with type 1 DM can exist in the absence of other 
combined cardiac problems.
4) 
Echocardiography can be used for the diagnosis of 
diabetic cardiomyopathy or diabetes-induced myocar-
dial dysfunction. In adults with type 1 DM, numerous 
studies have reported controversial results. Several in-
vestigators have shown normal LV systolic function at 
rest and abnormal contractile responses during exer-
cise.
2)7) With respect to LV diastolic function, several 
studies have reported an abnormal pattern,
8)9) whereas 
another study found no evidence of dysfunction at rest.
10) 
However, no studies have been conducted involving pa-
tients of a younger age with a shorter duration of DM 
and hyperglycemia.   
The aim of this study was to assess whether or not 
cardiac functional deterioration can be detected in pe-
diatric patients with type I DM and whether or not DM 
of a relatively short duration and hyperglycemia influence 
cardiac function. 
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Subjects and Methods 
 
Study population 
We studied 38 children and adolescents who parti-
cipated in the 2007 Diabetes Summer Education Camp 
in Daegu and 9 pediatric patients who were attending 
the Diabetes Clinic for Children of the Keimyung Uni-
versity Dongsan Medical Center. All patients were diag-
nosed with type I DM and received insulin therapy only. 
The patients consisted of 16 boys and 31 girls, with a 
mean age of 12.8 years (range, 7.1-16.8 years). The mean 
duration of disease was 3.4 years (range, 0.3-7.7 years). 
None of the patients had definite DM-induced compli-
cations, including renal impairment, retinopathy, neu-
ropathy, and clinical symptoms of cardiac dysfunction 
or cardiomyopathy. The conventional laboratory che-
mistry results were normal, except for the glycosylated 
hemoglobin (HbA1c) level. The control group consist-
ed of 38 children (18 boys and 20 girls), with a mean age 
of 11 years (range, 6.9-17.1 years). They were referred to 
us with a chief complaint of heart murmurs or chest 
pain, and did not show abnormal findings on labora-
tory testing, electrocardiograms, or echocardiography. 
 
Echocardiography 
An echocardiography was performed using an Acu-
son Sequire 512 (Siemens Medical Solution, Mountain 
View, CA, USA) with a 4 or 8 MHz transducer. All of 
the tests which were performed were saved on a hard 
drive and magneto-optical (MO) disk of echocardiogra-
phic equipment. On the parasternal long axis view, with 
the use of M-mode and conventional echocardiography, 
several parameters, including fractional shortening (FS), 
ejection fraction (EF), LV dimension, and volume per 
surface area, were measured. 
For diastolic functional analysis, the mitral inflow sig-
nal was acquired in an apical four-chamber view. The 
pulsed Doppler sample volume was 2 mm and it was 
placed at the mitral valve tip. The early peak flow velo-
city  (E) and atrial filling velocity (A) were measured 
three times and averaged, and the E/A ratio was calcu-
lated. The time elapsed until the maximal E reached the 
baseline {the early filling deceleration time (DT)}, and 
the time from aortic valve closure to mitral valve opening 
{the isovolumic relaxation time (IVRT)}, were measured. 
Tissue Doppler imaging (TDI) measurements were 
performed on the basal septum and mitral annulus. 
The maximal systolic myocardial velocity (S’) and early 
and late diastolic myocardial velocity (E’, A’) were meas-
ured. In this study, the sample volume was set at 3 mm. 
The time between mitral valve closure and opening (a’) 
and the systolic time (b’) were measured. The value of 
(a’-b’) was divided by b’ and the modified myocardial 
performance index (modified Tei index) was obtained. 
To analyze the vector velocity imaging (VVI), an ul-
trasound window of the images was controlled in such 
a manner that the number of frames should be >70 
frames per single cardiac beat on an apical 4-chamber 
view and 2D images were acoustically captured. Secured 
images were saved on a MO disk for off-line analysis. 
The contour of the endocardium was manually traced 
before the analysis was performed on the saved images 
with the use of an offline analysis program {Syngo US 
Workplace 3.0 (Simens Medical Solution, Mountain 
View, CA, USA)}. The tracing was performed several 
times to achieve the most appropriate endocardial con-
tour, which was confirmed by the visual display mode 
of the velocity images. In the septum and lateral wall 
of the LV, the basal and middle parts were subjected to 
the measurement of maximal velocity, strain, strain rate 
(SR), and displacement. 
All of the echocardiographic parameters obtained for 
pulsed wave Doppler and TDI were measured by a sin-
gle investigator from three cardiac cycles and averaged. 
The parameters which were obtained from the VVI were 
the average value of the measurement performed twice. 
 
Statistical analysis 
All of the results which were measured using echocar-
diography were expressed as the mean±SD. Statistical 
analysis was performed using Statistical Package for the 
Social Sciences (SPSS) for Windows, version 14.0 (SPSS 
Inc., Chicago, IL, USA). A comparison of echocardio-
graphic measurements in the septum and lateral wall of 
the LV between the patient and control groups was made 
with the use of an independent t-test. The correlation 
between echocardiographic parameters and the dura-
tion of DM or the HbA1c level was assessed using cor-
relation analysis. A p<0.05 was considered statistically 
significant.  
 
Results 
 
Patients 
The clinical data of the patients and controls are listed 
Table 1. Clinical characteristics of patients with diabetes melli-
tus and controls in the study groups 
  Patients with DM 
(n=47) 
Controls 
(n=38)  p
Gender  M (16)/F (31)  M (18)/F (20)   
Age (year)  12.84±2.26 11.03±2.61 0.014
Height (cm)  150.1±12.4 144.50±17.7 NS
Weight (kg)  44.7±11.0 39.6±14.8 NS
BMI (kg/m
2) 19.5±3.1 18.4±3.1 NS
Glycosylated 
 hemoglobin  (%) 8.4±2.1  -  
Duration of DM 
 (months)  42.37±27.20  -  
Continuous variables are expressed as the mean±standard deviat-
ion. DM: diabetes mellitus, M: male, F: female, BMI: body mass in-
dex, NS: non-specific 
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in Table 1. The age of patients was higher than the con-
trols (p=0.014). The number of patients with a dura-
tion of disease <36 months was 19 and the number of 
patients with a duration of disease >48 months was 18. 
 
Analysis of the cardiac function using 2-dimensional 
and Doppler methods   
The data derived from conventional echocardiogra-
phic analysis are listed in Table 2. The E velocity of the 
patients was significantly lower than that of controls 
(p=0.028). However, the other conventional echocar-
diographic parameters in the patient group, including 
mitral flow patterns, were not significantly different from 
the controls. Although the findings of pulsed wave TDI 
at the annular level showed a lower S’, E’, and E’/A’, and 
a higher Tei index in the patient group, these differences 
were not significant (Table 3).  
 
An analysis of the cardiac function using vector 
velocity imaging   
The regional myocardial velocity, strain, systolic and 
diastolic SR, and displacement findings evaluated at the 
basal and mid-septal, and basal and mid-lateral wall 
levels are listed in Table 4. These parameters also did 
not show significant differences between the patient and 
control groups.   
 
Relationship between duration of diabetes mellitus 
and echocardiographic parameters 
Characteristic and conventional echocardiographic 
data according to duration of DM are listed in Table 5. 
The group with a duration of DM >4 years had a higher 
HbA1c than the group with a duration of DM <3 years 
(p=0.01). The group with a duration of DM >4 years 
Table 2. Echocardiographic parameters derived from two-di-
mensional and Doppler imaging in the study groups 
Parameter  Patients with 
DM (n =47) 
Controls
(n=38)  p
End-diastolic diameter (mm)  4.2±0.4 4.1±0.5 NS
End-systolic diameter (mm)  2.6±0.3 2.6±0.4 NS
Diastolic septal thickness (mm)  0.8±0.2 0.8±0.2 NS
Diastolic posterior wall 
 thickness  (mm)  0.8±0.1 0.8±0.1 NS
End-diastolic volume (cm
3) 79.6±19.5 76.8±22.2 NS
End-systolic volume (cm
3) 24.6±7.4 25.4±9.0 NS
Stroke volume (mL)  55.0±15.6 51.4±16.3 NS
Cardiac output (L/min)  4.5±1.6 4.5±1.5 NS
Fractional shortening (%)  38.6±5.4 36.9±5.4 NS
Ejection fraction (%)  69.0±6.8 66.8±7.2 NS
E (cm/s)  99.2±16.5 107.6±17.4 0.028
A (cm/s)  50.5±11.0 51.9±10.3 NS
E/A ratio  2.1±0.6 2.1±0.5 NS
Mitral deceleration time (ms)  144.6±21.9 134.1±27.2 NS
Isovolumic relaxation 
 time  (ms)  59.2±9.6 59.6±10.2 NS
All measures are expressed as the mean±standard deviation. DM:
diabetes mellitus, NS: non-specific 
 
Table 4. Vector velocity imaging findings in the study groups
Parameter  Patients with 
DM (n=47) 
Controls 
(n=38)  p
Septum basal     
Systolic velocity (cm/s)  5.5±1.28 5.7±1.3 NS
Diastolic velocity (cm/s) 9.7±1.8 9.8±2.3 NS
Strain (%)  24.0±7.1 24.3±5.5 NS
Systolic strain rate (s-1) 1.9±0.7 1.9±0.7 NS
Diastolic strain rate (s-1)2 . 6 ±1.2 2.6±0.9 NS
Displacement (mm)  9.3±2.0 9.4±1.9 NS
Septum mid     
Systolic velocity (cm/s)  3.6±1.1 3.5±0.8 NS
Diastolic velocity (cm/s) 6.1±1.7 6.4±2.1 NS
Strain (%)  24.1±5.5 24.6±4.2 NS
Systolic strain rate (s-1) 1.9±0.5 1.8±0.4 NS
Diastolic strain rate (s-1)3 . 0 ±0.9 2.8±0.7 NS
Displacement (mm)  5.4±1.6 5.4±1.6 NS
Lateral basal     
Systolic velocity (cm/s)  6.7±1.5 6.1±1.8 NS
Diastolic velocity (cm/s) 11.6±3.4 10.9±2.6 NS
Strain (%)  24.1±6.6 24.7±6.0 NS
Systolic strain rate (s-1) 2.4±0.8 2.2±0.5 NS
Diastolic strain rate (s-1)2 . 7 ±1.1 2.7±1.1 NS
Displacement (mm)  10.7±2.6 10.0±2.9 NS
Lateral mid     
Systolic velocity (cm/s)  5.9±1.9 4.9±1.6 NS
Diastolic velocity (cm/s) 9.3±2.8 8.3±2.9 NS
Strain (%)  23.0±5.7 24.7±4.5 NS
Systolic strain rate (s-1) 2.0±0.7 1.9±0.5 NS
Diastolic strain rate (s-1)3 . 0 ±1.1 3.1±1.0 NS
Displacement (mm)  8.2±2.6 6.9±2.2 NS
All measures are expressed as the mean±standard deviation. DM:
diabetes mellitus, NS: non-specific 
 
Table 3. Tissue Doppler imaging findings in the study groups
Parameter  Patients with DM (n=47)  Controls (n=38) p
Septum    
S’ (cm/s)  9.3±1.2 9.5±1.2 NS
E’ (cm/s)  16.0±2.0 16.1±1.9 NS
A’ (cm/s)  7.2±1.4 6.6±1.6 NS
E’/A’ 2.3±0.5 2.6±1.7 NS
E/E’ 6.3±1.3 6.7±1.2 NS
Tei index  0.5±0.1 0.4±0.2 NS
Lateral    
S’ (cm/s)  12.2±2.5 11.3±2.5 NS
E’ (cm/s)  21.5±2.9 20.8±2.6 NS
A’ (cm/s)  6.9±1.4 6.6±1.5 NS
E’/A’ 3.2±0.7 3.3±0.7 NS
E/E’ 4.7±0.7 5.2±1.0 NS
Tei index  0.5±0.1 0.4±0.1 NS
All measures are expressed as the mean±standard deviation. DM:
diabetes mellitus, NS: non-specific 
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had a lower EF, FS, E velocity, and prolonged IVRT com-
pared to the group with a duration of DM <3 years; how-
ever, these results were not significantly different be-
tween the two groups. The findings of pulsed wave TDI 
at the annular level did not show significant differences. 
The regional myocardial systolic and diastolic velocities 
evaluated at the basal septum using VVI were lower in the 
group with a duration of DM >4 years than the group 
with a duration of DM <3 years and the control group 
(Table 6). Also, the regional myocardial systolic and dia-
stolic SRs evaluated at the basal and mid-septum were 
lower in the group with a duration of DM >4 years; how-
ever, none of the values were significantly different be-
tween the two groups.   
Based on the conventional and unconventional in-
Table 5. Baseline characteristics and echocardiographic para-
meters according to duration of DM 
Parameter 
Duration of 
DM <3 years 
(n=19) 
Duration of
DM >4 years
(n=18) 
p
Gender  M (6)/F (13)  M (6)/ F (12)
Duration of DM (months)  20 (3-29) 66(48-92)
Glycosylated hemoglobin 
 (%)  7.6±1.9 9.4±2.2 0.01
Conventional 
 echocardiography    
Fractional shortening (%)  38.7±5.1 37.8±4.9 NS
Ejection fraction (%)  69.0±6.5 68.1±6.1 NS
E (cm/s)  99.7±16.4 98.4±18.7 NS
A (cm/s)  48.9±8.6 52.7±14.0 NS
Mitral deceleration time 
 (ms)  148.5±20.3 143.6±26.0 NS
Isovolumic relaxation time 
 (ms)  58.1±9.6 60.3±9.2 NS
Tissue Doppler imaging     
Septum    
S’ (cm/s)  9.3±1.0 9.4±1.5 NS
E’ (cm/s)  16.4±1.8 16.2±2.3 NS
A’ (cm/s)  6.9±1.4 7.5±1.5 NS
E’/A’ 6.2±1.4 6.1±1.2 NS
Tei index  0.5±0.1 0.5±0.1 NS
Lateral    
S’ (cm/s)  12.5±2.6 11.9±2.4 NS
E’ (cm/s)  22.5±2.4 21.2±3.4 NS
A’ (cm/s)  6.7±0.9 7.1±1.5 NS
E’/A’ 4.5±0.9 4.6±0.8 NS
Tei index  0.5±0.1 0.5±0.2 NS
All measures are expressed as the mean±standard deviation. DM:
diabetes mellitus, M: male, F: female, NS: non-specific 
 
Table 6. Echocardiographic parameters derived from vector ve-
locity imaging according to duration of DM 
Parameter 
Duration of 
DM <3 years 
(n=19) 
Duration of 
DM >4 years 
(n=18) 
p
Septum basal     
Systolic velocity (cm/s)  5.5±1.0 5.1±1.0 NS
Diastolic velocity (cm/s) 9.9±1.5 9.1±1.9 NS
Strain (%)  25.3±7.6 25.7±4.0 NS
Systolic strain rate (s-1) 2.0±0.8 1.6±0.5 NS
Diastolic strain rate (s-1)2 . 7 ±1.3 2.3±0.8 NS
Displacement (mm)  9.7±1.9 8.5±1.7 NS
Septum mid     
Systolic velocity (cm/s)  3.6±1.0 3.5±1.2 NS
Diastolic velocity (cm/s) 6.2±1.9 6.1±1.8 NS
Strain (%)  25.5±5.4 25.0±2.8 NS
Systolic strain rate (s-1) 1.9±0.5 1.8±0.4 NS
Diastolic strain rate (s-1)3 . 2 ±0.9 2.6±0.7 NS
Displacement (mm)  5.6±1.8 5.1±1.5 NS
Lateral basal     
Systolic velocity (cm/s)  6.7±1.5 6.7±1.7 NS
Diastolic velocity (cm/s) 10.7±2.9 11.9±3.5 NS
Strain (%)  25.1±5.9 25.6±3.2 NS
Systolic strain rate (s-1) 2.5±0.9 2.3±0.7 NS
Diastolic strain rate (s-1)2 . 7 ±0.9 2.6±0.9 NS
Displacement (mm)  10.5±1.1 10.6±2.9 NS
Lateral mid     
Systolic velocity (cm/s)  6.1±2.2 5.6±1.8 NS
Diastolic velocity (cm/s) 9.2±2.8 9.4±3.1 NS
Strain (%)  24.2±4.4 25.2±4.0 NS
Systolic strain rate (s-1) 2.0±0.7 1.9±0.6 NS
Diastolic strain rate (s-1)2 . 9 ±1.2 2.9±0.8 NS
Displacement (mm)  8.2±2.7 7.9±2.4 NS
All measures are expressed as the mean±standard deviation. DM:
diabetes mellitus, NS: non-specific 
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dices of systolic and diastolic function, no significant re-
lationship existed between the duration of DM and echo-
cardiographic parameters. DT and E’/A’ had significant 
inverse correlations with HbA1c (Fig. 1) (p=0.042 and 
p=0.016, respectively). No significant relationship exist-
ed between the duration of DM or HbA1c and several 
parameters obtained from the VVI. 
 
Discussion 
 
This study yielded the following results: 1) no change 
of LV systolic function when evaluated by new sensi-
tive echocardiographic techniques, such as VVI, in the 
presence of normal systolic function during conventio-
nal and unconventional echocardiographic examina-
tions; 2) the change in LV diastolic function when ev-
aluated by conventional echocardiographic (transmi-
tral) examination in the presence of normal diastolic 
function during unconventional echocardiographic ex-
amination; 3) significant inverse correlations between 
conventional/unconventional echocardiographic para-
meters and HbA1c level; and 4) mild progression of 
LV systolic and diastolic functions from normal to dys-
function according to the duration of DM in spite of 
no significant differences between the groups.   
In the current study, LV systolic function was eva-
luated during the resting state and did not show a sig-
nificant difference between the two groups. The results 
of the current study, which documented normal con-
traction at rest, were the same as previous studies.
2)7) 
LV diastolic dysfunction in patients with DM may be 
caused by increased LV diastolic stiffness, deposition 
of advanced glycation end products, and cardiac fibrosis, 
all as a consequence of DM.
11)12) Previous studies have 
reported a change in early diastolic ventricular func-
tion in young adults with type I DM with normal LV 
EF.
8)9) The study to determine the relationship between 
LV diastolic dysfunction and the duration of DM de-
monstrated that a duration of DM >4 years was corre-
lated with significant LV diastolic dysfunction.
13) In com-
parison to the previous study, although LV diastolic func-
tion using mitral inflow Doppler analysis showed a sig-
nificant change in the DM group, LV diastolic function 
evaluated by TDI and VVI analysis, which were more 
sensitive for the detection of LV functional alteration, 
did not show a significant difference between the groups. 
The present data showed that there was no alteration 
in LV diastolic function in pediatric patients with type 
I DM. Indeed, the subjects in the current study were 
younger (mean age, 12 years and 5 months) and of sh-
orter disease duration (mean duration, 3 years and 5 
months). However, the striking finding involved the 
demonstration that LV functional alteration was based 
on the duration of DM. Although there were no signi-
ficant differences between the duration of DM in the 
>3 and >4 years groups, several echocardiographic pa-
rameters were lower in the group with a duration of DM 
>4 years. We therefore suggest that LV systolic and dia-
stolic function may progress from normal to subtle ch-
anges or dysfunction according to the duration of DM. 
In the current study, a higher HbA1c was associated 
with a lower DT and E’/A’. When LV compliance de-
creases and relaxation is abnormal, the DT becomes 
shorter and the E’/A’ ratio becomes <1.
14)15) The present 
data suggest that hyperglycemia induces changes in LV 
diastolic function, especially decreased compliance and 
relaxation. However, of the subjects in the present study, 
decreased DT and E’/A’ according to hyperglycemia, 
were not significantly different in comparison with the 
control group and do not necessarily indicate definite 
LV diastolic dysfunction. The influence of hyperglyce-
mia on LV function suggest that hyperglycemia may de-
crease the expression of sarco(endo)plasmic reticulum 
Ca2-ATPase (SERCA2a) and the SERCA2a-to-phosph-
olamban ratio.
16)17) These reports imply that active con-
trol of hyperglycemia and lowering blood glucose levels 
may attenuate these processes. Although it is difficult to 
clinically identify whether hyperglycemia is associated 
with myocardiac dysfunction in patients with DM, re-
cent echocardiographic studies have shown that correla-
tions exist between the state of glycemic control and ven-
tricular function. Recent studies involving adult patients 
with type 2 DM showed that hyperglycemia influences 
on LV systolic function, especially with respect to ven-
tricular long axis function.
18)19) A study using magnetic 
resonance imaging indicates that there is a correlation 
between hyperglycemia and LV function in type 1 DM 
as well.
20) The other study demonstrated that appro-
priate control of hyperglycemia improves LV function 
and reduced LV mass in type 1 DM patients,
21) and that 
there is a significant correlation between hyperglyce-
mic control and changes in LV function. In the cur-
rent study, LV diastolic function showed a significant 
and inverse correlation with HbA1c. Of importance, 
this finding was demonstrated in a very early stage of 
type I DM. We suggest that to maintain normal ventri-
cular function in patients with DM apart from the dur-
ation of DM, more aggressive control of blood glucose 
levels are needed and must be started as early as possible. 
The limitations of the present study were that the 
number of enrolled patients was relatively small and 
that it was a cross-sectional study in which a comparison 
was made without baseline data.   
Children and young adolescents rarely have insight 
on regarding their disease, and their diet is accordingly 
difficult to control. Therefore, alteration of myocardiac 
function induced by DM may begin earlier than is ge-
nerally thought and these changes may be accelerated 
when glycemic control is poor. We recommend that close 
observation should begin early and should include de- 
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tection of diabetic cardiac alterations, as well as other 
diabetic complications.   
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